These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20471651)

  • 1. Uraemic toxins for consideration by the cardiologist-Beyond traditional and non-traditional cardiovascular risk factors.
    Massy ZA; Barreto DV; Barreto FC; Vanholder R
    Atherosclerosis; 2010 Aug; 211(2):381-3. PubMed ID: 20471651
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease.
    Tonelli M; Karumanchi SA; Thadhani R
    Circulation; 2016 Feb; 133(5):518-36. PubMed ID: 26831434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vascular calcifications in patients with uremia: the hypothesis of the three ''culprits''].
    Cozzolino M
    G Ital Nefrol; 2009; 26(5):562. PubMed ID: 19802801
    [No Abstract]   [Full Text] [Related]  

  • 4. Intima-media thickness is associated with inflammation and traditional cardiovascular risk factors in non-dialysis-dependent patients with chronic kidney disease.
    Lemos MM; Jancikic AD; Sanches FM; Christofalo DM; Ajzen SA; Carvalho AB; Draibe SA; Canziani ME
    Nephron Clin Pract; 2010; 115(3):c189-94. PubMed ID: 20413996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin/cytokine profiles in haemodialysis and in continuous peritoneal dialysis.
    Jacobs P; Glorieux G; Vanholder R
    Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V41-45. PubMed ID: 15284359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From old uraemic toxins to new uraemic toxins: place of 'omics'.
    Massy ZA; Liabeuf S
    Nephrol Dial Transplant; 2018 Oct; 33(suppl_3):iii2-iii5. PubMed ID: 30281133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular biomarkers in chronic kidney disease.
    Park SH; Stenvinkel P; Lindholm B
    J Ren Nutr; 2012 Jan; 22(1):120-7. PubMed ID: 22200428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy.
    Himmelfarb J
    Semin Dial; 2009; 22(6):636-43. PubMed ID: 20017834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life in patients with uraemic xerosis and pruritus.
    Szepietowski JC; Balaskas E; Taube KM; Taberly A; Dupuy P;
    Acta Derm Venereol; 2011 May; 91(3):313-7. PubMed ID: 21369686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis.
    Van Biesen W; Verbeke F; Vanholder R
    Nephrol Dial Transplant; 2007 Jan; 22(1):53-8. PubMed ID: 17050633
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular calcification in nondialyzed patients with chronic kidney disease.
    Qunibi WY
    Semin Dial; 2007; 20(2):134-8. PubMed ID: 17374087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro haemodialysis.
    Segall L; Covic A
    Nephrol Dial Transplant; 2007 Jan; 22(1):59-63. PubMed ID: 17099221
    [No Abstract]   [Full Text] [Related]  

  • 13. [Renal biopsy in acute uremia. Therapeutic significance and implications for hospitals].
    Richet G; Sraer JD; Kourilsky O; Kanfer A; Morel-Maroger L
    Bull Acad Natl Med; 1979 Oct; 163(7):709-13. PubMed ID: 396964
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictors of cardiovascular death in ESRD.
    Zoccali C; Tripepi G; Mallamaci F
    Semin Nephrol; 2005 Nov; 25(6):358-62. PubMed ID: 16298255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter.
    Levin A; Djurdjev O; Barrett B; Burgess E; Carlisle E; Ethier J; Jindal K; Mendelssohn D; Tobe S; Singer J; Thompson C
    Am J Kidney Dis; 2001 Dec; 38(6):1398-407. PubMed ID: 11728982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enlargement of hemodialyzed spleen in uremia histopathological and biometrical studies compared with the kidney.
    Morohoschi T
    Acta Pathol Jpn; 1977 May; 27(3):283-95. PubMed ID: 920173
    [No Abstract]   [Full Text] [Related]  

  • 17. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.
    Yao Q; Pecoits-Filho R; Lindholm B; Stenvinkel P
    Scand J Urol Nephrol; 2004; 38(5):405-16. PubMed ID: 15764253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imatinib ameliorates fibrosis in uraemic cardiac disease in BALB/c without improving cardiac function.
    Baumann M; Leineweber K; Tewiele M; Wu K; Türk TR; Su S; Gössl M; Buck T; Wilde B; Heemann U; Kribben A; Witzke O
    Nephrol Dial Transplant; 2010 Jun; 25(6):1817-24. PubMed ID: 20061323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathological conference. XI. Chronic uremia in a child].
    Lappi R; Rapola J
    Duodecim; 1973; 89(14):1010-8. PubMed ID: 4761200
    [No Abstract]   [Full Text] [Related]  

  • 20. Coronary artery calcification progression and cardiovascular events in renal transplant recipients, bad inheritance from previous kidney disease: commentary on the study of Roe et al.
    Santos RD
    Atherosclerosis; 2010 Oct; 212(2):390-1. PubMed ID: 20619413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.